Nuventra Pharma Sciences, a United States-based clinical pharmacology consulting company, has named Daniel Roy, MHA as its new president, it was reported on Tuesday.
Roy joined the company in 2014 as manager of Marketing and Corporate Communication. He has served in various roles of increasing responsibility including senior director of Business Development and Marketing, and most recently as vice president of Corporate Strategy and Business Development. He has 16 years of experience in leadership, marketing, and business development. He will continue to serve as the company's chief executive officer.
Roy graduated from Ohio University with a Master of Healthcare Administration and acquired a Bachelor of Arts degree in Communication from East Carolina University.
Kibow Biotech receives AANP Corporation of the Year Award
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees